Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Severing the scar supply line: CAR-T in chronic kidney disease

Cell stem cell(2025)10.1016/j.stem.2025.08.002Source: DataRank Database

Severing the scar supply line: CAR-T in chronic kidney disease is a research paper published in Cell stem cell (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: closedTopics (8)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Yingxiao Wang ORCID,Longwei Liu ORCID

Live enrichment

PubMed:40912230

NIH

Grant: CA262815

NIH

Grant: GM140929

NIH

Grant: HL121365

NIH

Grant: HD107206

NIH

Grant: K01EB035649

NIH

Grant: EB029122

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S1934590925002942?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1934590925002942?httpAccept=text/plain

MeSH Terms

CicatrixAnimalsHumansFibrosisReceptor, Platelet-Derived Growth Factor betaImmunotherapy, AdoptiveRenal Insufficiency, ChronicReceptors, Chimeric Antigen